Two recent studies have re-analyzed published data and found that when datasets are 2 analyzed independently there was limited support for the widely accepted hypothesis that 3 changes in the microbiome are associated with obesity. This hypothesis was reconsidered 4 by increasing the number of datasets and pooling the results across the individual datasets. 5 The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 6 guidelines were applied to identify 10 studies for an updated and more synthetic analysis. 7 Alpha diversity metrics and the relative risk of obesity based on those metrics were used to 8 identify a limited number of significant associations with obesity; however, when the results 9 of the studies were pooled using a random effects model significant associations were 10 observed between Shannon diversity, number of observed OTUs, and Shannon evenness 11 and obesity status. They were not observed for the ratio of Bacteroidetes and Firmicutes 12 or their individual relative abundances. Although these tests yielded small P-values, the 13 difference between the Shannon diversity index of non-obese and obese individuals was 14 2.07%. A power analysis demonstrated that only one of the studies had sufficient power to 15 detect a 5% difference in diversity. When Random Forest machine learning models were 16 trained on one dataset and then tested using the other 9 datasets, the median accuracy 17 varied between 33.01 and 64.77% (median=56.68%). Although there was support for a 18 relationship between the microbial communities found in human feces and obesity status, 19 this association was relatively weak and its detection is confounded by large interpersonal 20 variation and insufficient sample sizes. 21 
Introduction
Obesity is a growing health concern with approximately 20% of the youth (aged 2-19) in 34 the United States classified as either overweight or obese (1). This number increases 35 to approximately 35% in adults (aged 20 or older) and these statistics have seen little 36 change since 2003 (1). Traditionally, the body mass index (BMI) has been used to classify 37 individuals as non-obese or obese (2). Recently, there has been increased interest in 38 the role of the microbiome in modulating obesity (3, 4) . If the microbiome does affect 39 obesity status, then manipulating the microbiome could have a significant role in the future 40 treatment of obesity and in helping to stem the current epidemic. 41 There have been several studies that report observing a link between the composition 42 of microbiome and obesity in animal models and in humans. The first such study used 43 genetically obese mice and observed the ratio of the relative abundances of Bacteroidetes 44 to Firmicutes (B:F) was lower in obese mice than lean mice (5). Translation of this result 45 to humans by the same researchers did not observe this effect, but did find that obese 46 individuals had a lower alpha-diversity than lean individuals (6). They also showed that the 47 relative abundance of Bacteroidetes and Firmicutes increased and decreased, respectively, 48 as obese individuals lost weight while on a fat or carbohydrate restricted diet (7) . Two 49 re-analysis studies by Walters et al. (8) and Finucane et al. (9) interrogated previously 50 published microbiome and obesity data and concluded that the previously reported 51 differences in community diversity and B:F among non-obese and obese individuals 52 could not be generalized. Regardless of the results using human populations, studies 53 using animal models where the community was manipulated with antibiotics or established 54 by colonizing germ-free animals with varied communities appear to support the association 55 since these manipulations yielded differences in animal weight (10) (11) (12) (13) . The purported 56 association between the differences in the microbiome and obesity have been widely 57 repeated with little attention given to the lack of a clear signal in human cohort studies. 58 4
The recent publication of additional studies that collected BMI data for each subject as 59 well as other studies that were not included in the earlier re-analysis studies offered the 60 opportunity to revisit the question relating the structure of the human microbiome to obesity. 61 One critique of the prior re-analysis studies is that the authors did not aggregate the results 62 across studies to increase the effective sample size. It is possible that there were small 63 associations within each study that were not statistically significant because the individual 64 studies lacked sufficient power. Alternatively, diversity metrics may mask the appropriate 65 signal and it is necessary to measure the association at the level of microbial populations. 66 The Walters re-analysis study demonstrated that Random Forest machine learning models 67 were capable of predicting obesity status within a single cohort, but did not attempt to test 68 the models on other cohorts. The purpose of this study was to perform a meta-analysis of 69 the association between differences in the microbiome and obesity status by analyzing 70 and applying a more systematic and synthetic approach than was used previously.
71

Results
72
Literature Review and Study Inclusion. To perform a robust meta-analysis and limit 73 inclusion bias, we followed the Preferred Reporting Items for Systematic Reviews and 74 Meta-Analyses (PRISMA) guidelines to identify the studies that we analyzed (14). A 75 detailed description of our selection process and the exact search terms are provided in 76 the Supplemental Text and in Figure 1 . Briefly, we searched PubMed for original research 77 studies that involved studying obesity and the human microbiome. The initial search 78 yielded 187 studies. We identified 10 additional studies that were not designed to explicitly 79 test for an association between the microbiome and obesity. We then manually curated 80 the 197 studies to select those studies that included BMI and 16S rRNA gene sequence 81 data. This yielded 11 eligible studies. An additional study was removed from our analysis 82 because no individuals in the study had a BMI over 30. Among the final 10 studies, 3 were 83 5 identified from our PubMed search (10, 15, 16) , 5 were originally identified from the 10 84 studies that did not explicitly investigate obesity but included BMI data (17-21), and two 85 datasets were used (22, 23) because these publications did not specifically look for any 86 metabolic or obesity conditions but had control populations and enabled us to help mitigate 87 against publication biases associated with the bacterial microbiome and obesity. The ten 88 studies are summarized in Table 1 . For comparison, two of these studies were included 89 in the Finucane re-analysis study (10, 21) and four of these studies were included in the 90 Walters re-analysis study (10, 15, 20, 21) . The 16S rRNA gene sequence data from each 91 study was re-analyzed using a similar approach based on previously described methods 92 for reducing the number of chimeric sequences and sequencing errors for 454 and Illumina 93 MiSeq data (24, 25) . The sequences were clustered into operational taxonomic units 94 (OTUs) using the average neighbor approach (26) and into taxonomic groupings based on 95 their classification using a naive Bayesian classifier (27). 96 Alpha diversity analysis. We calculated the Shannon diversity index, observed richness, 97 and Shannon evenness, the relative abundance of Bacteroidetes and Firmicutes, and 98 the ratio of their relative abundance (B:F) for each sample. Once we transformed each 99 of the six alpha diversity metrics to make them normally distributed, we used a t-test 100 to identify significant associations between the alpha diversity metric and whether an 101 individual was obese for each of the ten studies. The B:F and the relative abundance 102 of Firmicutes were not significantly associated with obesity in any study. We identified 103 seven P-values that were less than 0.05: three studies indicated obese individuals had 104 a lower richness, two studies indicated a significantly lower diversity, one study indicated 105 a significantly lower evenness, and one study indicated a significantly higher relative 106 abundance of Bacteroidetes (Figures 2 and S1). These results largely match those of the 107 Walters and Finucane re-analysis studies. Interestingly, although only two of the ten studies 108 observed the previously reported association between lower diversity and obesity, the 109 other studies appeared to have the same trend, albeit the differences were not statistically 110 6 significant. We used a random effects linear model to combine the studies using the 111 study as the random effect and found statistical support for decreased richness, evenness, 112 and diversity among obese individuals (all P<0.011). Although there was a significant 113 relationship between these metrics and obesity status, the effect size was quite small. 114 The obese individuals averaged 7.47% lower richness, 0.88% lower evenness, and 2.07% 115 lower diversity. There were no significant associations when we pooled the phylum-level 116 metrics across studies. These results indicate that obese individuals do have a statistically 117 significant lower diversity than non-obese individuals; however, it is questionable whether 118 the difference is biologically significant.
119
Relative risk. Building upon the alpha diversity analysis we calculated the relative risk of 120 being obese based on an individual's alpha diversity metrics relative to the median metric 121 for that study. Inspection of funnel plots for each of the metrics suggested that the studies 122 included in our analysis were not biased ( Figure S2 ). The results using relative risk largely 123 matched those of using the raw alpha diversity data. Across the ten studies and six metrics, 124 the only significant relative risk values were the richness, evenness, and diversity values 125 from the Goodrich study (Figures 3 and S3 ). Again, although the relative risk values were 126 not significant for other studies, the values tended to be above one. When we pooled the 127 data using a random effects model, the relative risk associated with having a richness, 128 evenness, or diversity below the median for the population was significantly associated 129 with obesity (all P<0.0044). The relative risks associated with alpha diversity were small. 130 The relative risk of having a low richness was 1.30 (95% CI: 1.13-1.49), low evenness was 131 1.20 (95% CI: 1.06-1.37), and low diversity was 1.27 (95% CI: 1.09-1.48). There were no 132 significant differences in the phylum-level metrics. Again, the relative risk results indicate 133 that individuals with a lower richness, evenness, or diversity are at statistically significant 134 increased risk of being obese, it is questionable whether that risk is biologically or clinically 135 relevant. 136 7 Beta diversity analysis. Following the approach used by the Walters and Finucane 137 re-analysis studies, for each dataset we calculated a Bray-Curtis distance matrix to 138 measure the difference in the membership and structure of the individuals from each 139 study. We then used AMOVA to test for significant differences between the structure 140 of non-obese and obese individuals ( Table 1 ). The Escobar, Goodrich, and Turnbaugh 141 datasets indicated a significant difference in community structure (all P<0.05). Because 142 it was not possible to ascertain the directionality of the difference in community structure 143 because the samples are arrayed in a non-dimensional space or perform a pooled analysis 144 using studies that had non-overlapping 16S rRNA gene sequence regions, it is unclear 145 whether these differences reflect a broader, but perhaps small, shift in community structure 146 between non-obese and obese individuals. Figure 4A ). To test models 154 on other datasets, we trained models using genus-level phylotype data for each dataset. 155 The cross-validated AUC values for the models applied to the training datasets varied 156 between 0.51 and 0.65, again indicating a relatively poor ability to classify individuals from 157 the original dataset ( Figure 4B ). For each model we identified the probability where the 158 sum of the sensitivity and specificity was the highest. We then used this probability to 159 define a threshold for calculating the accuracy of the models when applied to the other 160 nine datasets ( Figure 5 ). Although there was considerable variation in accuracy values 161 for each model, the median accuracy for each model varied between 0.33 (Turnbaugh) 162 and 0.65 (HMP) (median=0.57). We built similar models using taxonomic representation 163 8 based on phylum, class, order, and family assignments and saw no improvement in the 164 results ( Figure S4 ). We also attempted to predict individual BMI values as continuous 165 variables based on the relative abundance of OTUs and genera. The median percent of the 166 variance explained with the resulting models was 12.9% for the OTU-based models and 167 8.2% for the genus-based models. When we considered the number of samples, balance 168 of non-obese and obese individuals, and region within the 16S rRNA gene for each study 169 it was not possible to identify factors that predictably affected model performance. The 170 ability to predict obesity status using relative abundance data from the communities was 171 only marginally better than random. These results suggest that given the large diversity of 172 microbiome compositions it is difficult to identify a taxonomic signal that can be associated 173 with obesity.
174
Power and Sample Size Estimate Simulations. The inability to detect a difference 175 between non-obese and obese individuals could be due to the lack of a true effect or 176 because the study had insufficient statistical power to detect a difference because of 177 insufficient sampling, large interpersonal variation, or unbalanced sampling of non-obese 178 and obese individuals. To assess these factors, we calculated the power to detect 179 differences of 1, 5, 10, and 15% in each of the alpha diversity metrics using the sample 180 sizes used in each of the studies (Figures 6, S5-S10). Although there is no biological 181 rationale for these effect sizes, they represent a range that includes effect sizes that would 182 be generally considered to be biologically significant. Only the Goodrich study had power 183 greater than 0.80 to detect a 5% difference in Shannon diversity and six of the studies had 184 enough power to detect a 10% difference ( Figure 6A ). None of the studies had sufficient 185 power to detect a 15% difference between B:F values ( Figure S5 ). In fact, the maximum 186 power among any of the studies to detect a 15% difference in B:F values was 0.25. Among 187 the tests for relative risk, none of the studies had sufficient power to detect a Cohen's d 188 of 0.10 and only two studies had sufficient power to detect a Cohen's d of 0.15. We next 189 estimated how many individuals would need to have been sampled to have sufficient power 190 9 to detect the four effect sizes assuming the observed interpersonal variation from each 191 study and balanced sampling between the two groups ( Figure 6B ). To detect a 1, 5, 10, or 192 15% difference in Shannon diversity, the median required sampling effort per group was 193 approximately 3,400, 140, 35, or 16 individuals, respectively. To detect a 1, 5, 10, and 15% 194 difference in B:F values, the median required sampling effort per group was approximately 195 160,000, 6,300, 1,600, or 700 individuals, respectively. To detect a 1, 5, 10, and 15% 196 difference in relative risk values using Shannon diversity, the median required sampling 197 effort per group was approximately 39, 000, 1,500, 380, or 170 individuals, respectively. 198 These estimates indicate that most microbiome studies are underpowered to detect modest 199 effect sizes using either metric. In the case of obesity, the studies were underpowered to 200 detect the 0.90 to 6% difference in diversity that was observed across the studies.
201
Discussion
202
Our meta-analysis helps to provide clarity to the ongoing debate of whether or not there 203 are specific microbiome-based markers that can be associated with obesity. We performed 204 an extensive literature review of the existing studies on the microbiome and obesity and 205 performed a meta-analysis on the studies that remained based on our inclusion and 206 exclusion criteria. By statistically pooling the data from ten studies, we observed significant, 207 but small, relationships between richness, evenness, and diversity and obesity status as 208 well as the relative risk of being obese based on these metrics. We also generated Random 209 Forest machine learning models trained on each dataset and tested on the remaining 210 datasets. This analysis demonstrated that the ability to reliably classify individuals as 211 being obese based solely on the composition of their microbiome was limited. Finally, 212 we assessed the ability of each study to detect defined differences in alpha diversity and 213 observed that most studies were underpowered to detect modest effect sizes. Considering 214 these datasets are among the largest published, it appears that most human microbiome 215 10 studies are underpowered to detect differences in alpha diversity. 216 Alpha diversity metrics are attractive because they distill a complex dataset to a single 217 value. For example, Shannon diversity is a measure of the entropy in a community and 218 integrates richness and evenness information. Two communities with little taxonomic 219 similarity can have the same diversity. Among ecologists the relevance of these metrics is 220 questioned because it is difficult to ascribe a mechanistic interpretation to their relationship 221 with stability or disease. Regardless, the concept of a biologically significant effect size 222 needs to be developed among microbiome researchers. Alternative metrics could include 223 the ability to detect a defined difference in the relative abundance of an OTU representing a 224 defined relative abundance. What makes for a biologically significant difference or relative 225 abundance is an important point that has yet to be discussed in the microbiome field. The 226 use of operationally defined effect sizes should be adequate until it is possible to decide 227 upon an accepted practice. 228 By selecting a range of possible effect sizes, we were able to demonstrate that most studies 229 are underpowered to detect modest differences in alpha diversity metrics and phylum-level 230 relative abundances. Several factors interact to limit the power of microbiome studies. 231 There is wide interpersonal variation in the diversity and structure of the human microbiome. 232 Some factors such as relationship between subjects could potentially decrease the amount 233 variation (6) and other factors such as whether one lives in a rural environment could 234 increase the amount of variation (28). In addition, the common experimental designs limit 235 their power. As we observed, most of the studies included in our analysis were unbalanced 236 for the variable that we were interested in. This was also true of those studies that originally 237 sought to identify associations with obesity. Even with a balanced design, we showed that 238 it was necessary to obtain approximately 140 and 6,300 samples per group to detect a 5% 239 difference in Shannon diversity or B:F, respectively. It was interesting that these sample 240 sizes agreed across studies regardless of their sequencing method, region within the 16S 241 rRNA gene, or subject population ( Figure 6 ). This suggests that regardless of the treatment 242 or category, these sample sizes represent a good starting point for subject recruitment 243 when using stool samples. Unfortunately, few studies have been published with this level 244 of subject recruitment. This is troubling since the positive predictive rate of a significant 245 finding in an underpowered study is small leading to results that cannot be reproduced 246 (29) . Future microbiome studies should articulate the basis for their experimental design. 247 Two previous re-analysis studies have stated that there was not a consistent association 248 between alpha diversity and obesity (8, 9) ; however, neither of these studies made an 249 attempt to pool the existing data together to try and harness the additional power that 250 this would give and they did not assess whether the studies were sufficiently powered 251 to detect a difference. Additionally, our analysis used 16S rRNA gene sequence data 252 from ten studies whereas the Finucane study used 16S rRNA gene sequence data from 253 three studies (7, 10, 21) and a metagenomic study (30) and the Walters study used 254 16S rRNA gene sequence data from five studies (10, 15, 20, 21, 28) ; two studies were 255 included in both analyses (10, 21) . Our analysis included four of these studies (10, 15, 256 20, 21) and excluded three of the studies because they were too small (7), only utilized 257 metagenomic data (30), or used short single read Illumina HiSeq data that has a high 258 error rate making it intractable for de novo OTU clustering (28). The additional seven 259 datasets were published after the two reviews were performed and include datasets with 260 more samples than were found in the original studies. Our collection of ten studies allowed 261 us to largely use the same sequence analysis pipeline for all datasets and relied heavily 262 on the availability of public data and access to metadata that included variables beyond 263 the needs of the original study. To execute this analysis, we created an automated data 264 analysis pipeline, which can be easily updated to add additional studies as they become 265 available (https://github.com/SchlossLab/Sze_Obesity_mBio_2016/). Similarly, it would be 266 possible to adapt this pipeline to other body sites and treatment or variables (e.g. subject's 267 sex or age). 268 Similar to our study, the Walters study generated Random Forest machine learning models 269 to differentiate between non-obese and obese individuals (8). They obtained similar AUC 270 values to our analysis; however, they did not attempt to test these models on the other 271 studies in their analysis. When we performed the inter-dataset cross validation the median 272 accuracy across datasets was only 56.68% indicating that the models did a poor job when 273 applied to other datasets. This could be due to differences in subject populations and 274 methods. Furthermore, others have reported improved classification at broader taxonomic 275 levels (31); we did not find this to be the case across the studies in our analysis ( Figure   276 S4). Considering the median AUC for models trained and tested on the same data with 277 ten-fold cross validation only varied between 0.51 and 0.65 and that there was not a strong 278 signal in the alpha diversity data, we suspect that there is insufficient signal to reliably 279 classify individuals to a BMI category based on their microbiota. 280 Although we failed to find an effect this does not necessarily mean that there is no role 281 for the microbiome in obesity. There is strong evidence in murine models of obesity that 282 the microbiome and level of adiposity can be manipulated via genetic manipulation of the 283 animal and manipulation of the community through antibiotics or colonizing germ free mice 284 with diverse fecal material from human donors (5, (10) (11) (12) (13) . These studies appear to conflict 285 with the observations using human subjects. Recalling the large interpersonal variation in 286 the structure of the microbiome, it is possible that each individual has their own signatures 287 of obesity. Alternatively, it could be that the involvement of the microbiome in obesity is not 288 apparent based on the taxonomic information provided by 16S rRNA gene sequence data. 289 Rather, the differences could become more apparent at the level of a common set of gene 290 transcripts or metabolites that can be produced from different structures of the microbiome. Sequence Analysis Pipeline. All sequence data were publicly available and were 293 downloaded from the NCBI Sequence Read Archive, the European Nucleotide Archive, 294 or the investigators' personal website (https://gordonlab.wustl.edu/TurnbaughSE/_10/_09/ 295 STM/_2009.html). In total seven studies used 454 (6, 15, 16, 18, (20) (21) (22) and three studies 296 used Illumina sequencing (17, 19, 23) . All of these studies used amplification-based 297 16S rRNA gene sequencing. Among the studies that sequenced the 16S rRNA gene, 298 the researchers targeted the V1-V2 (20), V1-V3 (15, 16, 18) , V3-V5 (21, 22) , V4 [(19); 299 (23); ], and V3-4 (17) regions. For those studies where multiple regions were sequenced, 300 we selected the region that corresponded to the largest number of subjects (6, 21). We 301 processed the 16S rRNA gene sequence data using a standardized mothur pipeline. Briefly, 302 our pipelines attempted to follow previously recommended approaches for 454 and Illumina 303 sequencing data (24, 25) . All sequences were screened for chimeras using UCHIME and 304 assigned to operational taxonomic units (OTUs) using the average neighbor algorithm 305 using a 3% distance threshold (26, 32). All sequence processing was performed using 306 mothur (v.1.37.0) (33).
307
Data Analysis. We split the overall meta-analysis into three general strategies using R 308 (3.3.0). First, we followed the approach employed by Finucane et al (9) Next, we compared the community structure from non-obese and obese individuals using 318 analysis of molecular variance (AMOVA) with Bray-Curtis distance matrices (36). This 319 analysis was performed using the vegan (v.2.3-5) R package. For both analyses, the 320 datasets were rarefied (N=1000) so that each study had the same number of sequences. 321 Second, for each study we partitioned the subjects into a low or high group depending 322 on whether their alpha diversity metrics were below or above the median value for the 323 study. The relative risk (RR) was then calculated as the ratio of the number of obese 324 individuals in the low group to the number of obese individuals in the high group. We then 325 performed a Fisher exact-test to investigate whether the RR was significantly different from 326 1.0 within each study and across all of the studies using the epiR (0.9-77) and metafor 327 (1.9-8) packages. Third, we used the AUCRF (1.1) R package to generate Random Forest 328 models (37). For each study we developed models using either OTUs or genus-level 329 phylotypes. The quality of each model was assessed by measuring the area under the 330 curve (AUC) of the Receiver Operating Characteristic (ROC) using ten-fold cross validation. 331 Because the genus-level phylotype models were developed using a common reference, it 332 was possible to use one study's model (i.e. the training set) to classify the samples from 333 the other studies (i.e. the testing sets). The optimum threshold for the training set was set 334 as the probability threshold that had the highest combined sensitivity and specificity. This 335 threshold was then used to calculate the accuracy of the model applied to the test studies. 336 To generate ROC curves and calculate the accuracy of the models we used the pROC (1.8) 337 R package (38). Finally, we performed power and sample number simulations for different 338 effect sizes for each study using the pwr (1.1-3) R package and base R functions. We also 339 calculated the actual sample size needed based on the effect size of each individual study. Table 1 . Summary of obesity, demographic, sequencing, and beta-diversity analysis data for the studies used in the meta-analysis. NA indicates that those metadata were not available for that study. 
